MAPT and progressive supranuclear palsy: Piras et al. (2016) showed that hyperphosphorylated tau was co-localized on surfaces labeled for LC3-II and p62 proteins in the brain of patients with progressive supranuclear palsy and corticobasal degeneration (Piras et al. 2016).